| Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent LP Dwoskin, AS Rauhut, KA King‐Pospisil, MT Bardo CNS drug reviews 12 (3‐4), 178-207, 2006 | 319 | 2006 |
| A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse LP Dwoskin, PA Crooks Biochemical pharmacology 63 (2), 89-98, 2002 | 291 | 2002 |
| Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Peris, SJ Boyson, WA Cass, P Curella, LP Dwoskin, G Larson, LH Lin, ... The journal of pharmacology and experimental therapeutics 253 (1), 38-44, 1990 | 277 | 1990 |
| Obesity: Current and potential pharmacotherapeutics and targets V Narayanaswami, LP Dwoskin Pharmacology & therapeutics 170, 116-147, 2017 | 237 | 2017 |
| Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions JL Perry, JE Joseph, Y Jiang, RS Zimmerman, TH Kelly, M Darna, P Huettl, ... Brain research reviews 65 (2), 124-149, 2011 | 221 | 2011 |
| Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine MT Bardo, SL Bowling, JK Rowlett, P Manderscheid, ST Buxton, ... Pharmacology Biochemistry and Behavior 51 (2-3), 397-405, 1995 | 190 | 1995 |
| Lobeline and nicotine evoke [3H] overflow from rat striatal slices preloaded with [3H] dopamine: differential inhibition of synaptosomal and vesicular [3H] dopamine uptake L Teng, PA Crooks, PK Sonsalla, LP Dwoskin The Journal of pharmacology and experimental therapeutics 280 (3), 1432-1444, 1997 | 172 | 1997 |
| Vesicular monoamine transporter 2: role as a novel target for drug development G Zheng, LP Dwoskin, PA Crooks The AAPS journal 8, E682-E692, 2006 | 171 | 2006 |
| Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery LP Dwoskin, PA Crooks The Journal of pharmacology and experimental therapeutics 298 (2), 395-402, 2001 | 166 | 2001 |
| Lobeline attenuates d-methamphetamine self-administration in rats SB Harrod, LP Dwoskin, PA Crooks, JE Klebaur, MT Bardo The Journal of pharmacology and experimental therapeutics 298 (1), 172-179, 2001 | 157 | 2001 |
| (S)-(−)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H] dopamine release from rat striatal slices in a calcium-dependent manner LP Dwoskin, L Teng, ST Buxton, PA Crooks The Journal of pharmacology and experimental therapeutics 288 (3), 905-911, 1999 | 154 | 1999 |
| Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex J Zhu, S Apparsundaram, MT Bardo, LP Dwoskin Journal of neurochemistry 93 (6), 1434-1443, 2005 | 152 | 2005 |
| Nornicotine is self-administered intravenously by rats MT Bardo, TA Green, PA Crooks, LP Dwoskin Psychopharmacology 146, 290-296, 1999 | 150 | 1999 |
| Lobeline Displaces [3H]Dihydrotetrabenazine Binding and Releases [3H]Dopamine from Rat Striatal Synaptic Vesicles: Comparison with d‐Amphetamine LH Teng, PA Crooks, LP Dwoskin Journal of neurochemistry 71 (1), 258-265, 1998 | 146 | 1998 |
| Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking PA Crooks, LP Dwoskin Biochemical pharmacology 54 (7), 743-753, 1997 | 146 | 1997 |
| Effect of bupropion on nicotine self-administration in rats AS Rauhut, N Neugebauer, LP Dwoskin, MT Bardo Psychopharmacology 169, 1-9, 2003 | 131 | 2003 |
| Lobeline inhibits the neurochemical and behavioral effects of amphetamine DK Miller, PA Crooks, L Teng, JM Witkin, P Munzar, SR Goldberg, JB Acri, ... The Journal of pharmacology and experimental therapeutics 296 (3), 1023-1034, 2001 | 129 | 2001 |
| Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2′-14C] nicotine OA Ghosheh, LP Dwoskin, DK Miller, PA Crooks Drug Metabolism and Disposition 29 (5), 645-651, 2001 | 128 | 2001 |
| Robust modulation of [3H] dopamine release from rat striatal slices by D-2 dopamine receptors. LP Dwoskin, NR Zahniser The Journal of pharmacology and experimental therapeutics 239 (2), 442-453, 1986 | 128 | 1986 |
| Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2′-14C] nicotine O Ghosheh, LP Dwoskin, WK Li, PA Crooks Drug Metabolism and Disposition 27 (12), 1448-1455, 1999 | 125 | 1999 |
